Next-generation sequencing - feasibility and practicality in haematology

Area of Science:

• Molecular Biology
• Oncology
• Genomics

Background:

• Next-generation sequencing (NGS) platforms have advanced significantly, enabling precise and thorough detection of molecular mutations within complex tumor samples.
• The application of NGS in laboratory settings is rapidly evolving, offering new possibilities for molecular diagnostics.

Purpose of the Study:

• To review the feasibility and practicality of next-generation sequencing technology for laboratory use.
• To highlight the utility of NGS in characterizing hematological neoplasms and significant findings in major hematological malignancies.
• To discuss deep-sequencing strategies for analyzing numerous molecular markers for disease classification, patient stratification, and minimal residual disease monitoring.

Main Methods:

• Review of current literature on next-generation sequencing applications in hematological malignancies.
• Analysis of deep-sequencing strategies for molecular marker analysis.
• Evaluation of technical performance and clinical utility of amplicon deep-sequencing.

Main Results:

• NGS provides accurate and comprehensive molecular mutation detection in heterogeneous tumor specimens.
• Specific focus on the application of NGS in characterizing hematological neoplasms and identifying key mutations in malignancies.
• Deep-sequencing strategies are crucial for managing an increasing number of molecular markers.

Conclusions:

• Amplicon deep-sequencing shows promising technical performance for routine diagnostic laboratory application.
• NGS technology is poised to impact clinical practice in hematological oncology through improved disease classification, patient stratification, and monitoring.
• Continued development of NGS assays is essential for realizing their full clinical potential.